周三盘中，生物科技公司传奇生物（股票代码：LEGN）股价出现大幅下跌，跌幅达5.02%，引发市场关注。
据悉，加拿大皇家银行资本市场（RBC Capital Markets）最近下调了传奇生物的目标价，从84美元下调至78美元。分析师的这一举动可能是导致股价下跌的主要原因之一，反映出市场对公司未来表现预期的调整。
值得注意的是，传奇生物的股价在前一个交易日已经出现了4.01%的跌幅，收于31.08美元。连续两个交易日的下跌显示出投资者对该公司短期前景的担忧情绪正在加剧。作为一家专注于开发新型细胞疗法的临床阶段生物制药公司，传奇生物的股价表现与其研发进展和市场预期密切相关。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.